1. Home
  2. FSLY vs VCEL Comparison

FSLY vs VCEL Comparison

Compare FSLY & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fastly Inc.

FSLY

Fastly Inc.

HOLD

Current Price

$30.11

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$44.20

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSLY
VCEL
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.4B
IPO Year
2019
1996

Fundamental Metrics

Financial Performance
Metric
FSLY
VCEL
Price
$30.11
$44.20
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$18.00
$57.75
AVG Volume (30 Days)
6.5M
460.7K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.19
60.00
EPS
N/A
N/A
Revenue
$624,018,000.00
$276,259,000.00
Revenue This Year
$16.39
$19.40
Revenue Next Year
$10.73
$18.24
P/E Ratio
N/A
N/A
Revenue Growth
14.78
16.45
52 Week Low
$6.84
$28.95
52 Week High
$34.82
$49.32

Technical Indicators

Market Signals
Indicator
FSLY
VCEL
Relative Strength Index (RSI) 73.06 46.04
Support Level $23.88 $32.44
Resistance Level $33.79 $49.04
Average True Range (ATR) 2.12 1.56
MACD 0.74 -0.39
Stochastic Oscillator 93.58 16.94

Price Performance

Historical Comparison
FSLY
VCEL

About FSLY Fastly Inc.

Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: